US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 37.500
  • -0.480-1.26%
Trading Jul 22 11:13 ET
4.55BMarket Cap-10932P/E (TTM)

Apellis Pharmaceuticals Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Jul 22, 2024

Based on 14 analysts giving stock ratings to Apellis Pharmaceuticals in the past 3 months

Strong Buy

  • Buy

    78.57%
  • Hold

    21.43%
  • Sell

    0.00%

Price Target

Updated: Jul 22, 2024

The average Apellis Pharmaceuticals stock price target is 72.58 with a max estimate of 95.00 and a min estimate of 46.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Jul 22, 2024

Strong Buy

  • Buy

    78.57%
  • Hold

    21.43%
  • Sell

    0.00%

Price Target

Updated: Jul 22, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg